Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 27454
Evènement :2nd Annual NASH Summit Europe

Dates :Lundi 22 Octobre 2018 - Mercredi 24 Octobre 2018

Lieu :Sheraton Frankfurt Airport Hotel And Conference Center
Airport/Terminal 1, Hugo Eckener Ring 15, Frankfurt Airport
60549 Frankfurt am Main, Allemagne

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--




Built from research with the FDA, EMA and Gilead, the 2nd Annual NASH Summit Europe will once again elevate industry-to-industry dialogue and reveal leading insights in overcoming the hurdles limiting NASH therapeutic success.
Join the NASH community as they collectively address the biggest challenges in NASH through a tighter lens including the potential for stand-alone versus combination therapeutics, the genetic drivers influencing disease heterogeneity and the future payer and reimbursement landscape.
Hear from 22 stakeholders including Pfizer, Novartis and MedImmune as this exclusively drug development driven forum equips you with the connections and actionable takeaways you need to capture one of many market opportunities for a successful NASH candidate.
GOLD: Conference + 2 Workshops (Early Bird - Ends 10/08/2018): EUR 2797.0
GOLD: Conference + 2 Workshops: EUR 2997.0
SILVER Conference + 1 Workshop (Early Bird - Ends 10/08/2018): EUR 2298.0
SILVER Conference + 1 Workshop: EUR 2498.0
BRONZE Conference Only (Early Bird - Ends 10/08/2018): EUR 1799.0
BRONZE Conference Only: EUR 1999.0
Workshops Only : EUR 599.0
Speakers: Adil Mardinoglu, (Assistant Professor of Systems Biology, Royal Institute of Technology (KTH)), Aimo Kannt, (Cluster Head Comorbidities And Complications of Diabetes, ,Sanofi), Andreas Geier, (Head of Hepatology ,University of Wurzburg), Bill Esler, (Senior Director ,Pfizer), David Fraser, (Chief Scientific Officer ,NorthSea Therapeutics), Dimitar Tonev, (Honorary Consultant ,HCV Research UK),Donna Cryer, (President And Chief Executive Officer ,Global Liver Institute), Donny Wong, (Global Analytics And Insight Lead, CVRM Early Assets ,AstraZeneca), Eric Hughes, (Head of Global Development Franchise, Immunology And Dermatology ,Novartis), Jonathan Roth, (Senior Director, Head Preclinical And Translational Biology ,Mistral Therapeutics), Gabriel Baverel, (President And Chief Executive Officer ,Metabolys), Henning Gronbaek, (Professor Internal Medicine And Hepatology ,Aarhus University), Meena Jain, (Director, Clinical Development, Cardiovascular And Metabolic Disease, MedImmune), Nikolai Naoumov, (Executive Director, Hepatology Science And Innovation, Novartis), Pietro Scalfaro, (Chief Medical Officer ,Enyo Pharmaceuticals), Rebecca Taub, (Chief Medical Officer, Executive Vice President Research And Development ,Madrigal Pharmaceuticals), Richard Lee, (Director,Ionis Pharmaceuticals), Sebastien Bolze, (Chief Scientific Officer, Poxel Pharmaceuticals), Sophie Megnien, (Chief Medical Officer ,Genfit), Stephen Rossi, (Senior Director, Clinical Development And Medical Affairs ,NGM Biopharmaceuticals) ,Suneil Hosmane, (Executive Vice President - Strategic Development ,Genfit)
Time: 8:00 am to 5:30 pm


Plan et itinéraire
Adresse de la conférence :
Sheraton Frankfurt Airport Hotel And Conference Center
Airport/Terminal 1, Hugo Eckener Ring 15, Frankfurt Airport
60549 Frankfurt am Main
Plan et itinéraire


Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama


2nd Annual NASH Summit Europe Médecine interne
science, health and medicine, pharmaceuticals, drug discovery
Tout public
-- -- --


Pour plus d'informations sur 2nd Annual NASH Summit Europe, veuillez contacter Hanson Wade

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama

Recommander cet évènement